한국어
English
日本語
中文(简体)Approval withdrawn
Akinji Injection
13mg
Injections · Prescription medication · Combination
HK inno.N Co., Ltd.
Fosnetupitant hydrochloride is an ingredient that prevents nausea and vomiting during cancer treatment.
MFDS ingredient code M283221
Fosnetupitant hydrochloride belongs to the class of antiemetics that block neurotransmitter receptors. It is used for the purpose of preventing nausea and vomiting caused by chemotherapy.
This ingredient blocks specific receptors in the brain and the intestines, preventing the signaling that induces nausea and vomiting. This effectively reduces the symptoms of nausea and vomiting that occur during cancer treatment.
Approved uses differ by product. Check each product's information for its actual use.
Unlike conventional antiemetics, fosnetupitant hydrochloride is converted into an active form in the body and acts quickly. This results in a characteristic of long-lasting anti-vomiting effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.